Invesco’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.6M Buy
908,414
+355,883
+64% +$4.15M ﹤0.01% 1740
2025
Q1
$4.11M Buy
552,531
+378,940
+218% +$2.82M ﹤0.01% 2246
2024
Q4
$1.04M Buy
173,591
+4,985
+3% +$29.9K ﹤0.01% 2895
2024
Q3
$863K Sell
168,606
-3,254
-2% -$16.7K ﹤0.01% 2966
2024
Q2
$622K Sell
171,860
-2,696
-2% -$9.76K ﹤0.01% 3170
2024
Q1
$560K Buy
174,556
+66,015
+61% +$212K ﹤0.01% 3258
2023
Q4
$532K Buy
108,541
+1,215
+1% +$5.95K ﹤0.01% 3169
2023
Q3
$585K Sell
107,326
-2,860
-3% -$15.6K ﹤0.01% 3114
2023
Q2
$739K Buy
110,186
+3,775
+4% +$25.3K ﹤0.01% 3025
2023
Q1
$940K Buy
106,411
+12,316
+13% +$109K ﹤0.01% 2917
2022
Q4
$719K Buy
94,095
+2,380
+3% +$18.2K ﹤0.01% 3080
2022
Q3
$653K Sell
91,715
-2,780
-3% -$19.8K ﹤0.01% 3089
2022
Q2
$764K Sell
94,495
-51,305
-35% -$415K ﹤0.01% 3097
2022
Q1
$2.02M Sell
145,800
-1,403,282
-91% -$19.5M ﹤0.01% 2766
2021
Q4
$43.5M Buy
1,549,082
+36,538
+2% +$1.03M 0.01% 1107
2021
Q3
$51.4M Sell
1,512,544
-20,090
-1% -$683K 0.01% 1037
2021
Q2
$62.6M Buy
1,532,634
+213,167
+16% +$8.71M 0.02% 990
2021
Q1
$53.1M Sell
1,319,467
-204,963
-13% -$8.25M 0.01% 1034
2020
Q4
$90.1M Buy
1,524,430
+254,801
+20% +$15.1M 0.03% 779
2020
Q3
$61.7M Buy
1,269,629
+38,792
+3% +$1.89M 0.02% 843
2020
Q2
$59.5M Buy
1,230,837
+1,006,018
+447% +$48.7M 0.02% 823
2020
Q1
$6.25M Sell
224,819
-30,549
-12% -$849K ﹤0.01% 1763
2019
Q4
$7.64M Buy
255,368
+25,614
+11% +$766K ﹤0.01% 1916
2019
Q3
$7.1M Buy
229,754
+4,754
+2% +$147K ﹤0.01% 1922
2019
Q2
$10.9M Buy
+225,000
New +$10.9M ﹤0.01% 1708